 NASHVILLE, Tenn.--BUSINESS WIRE--- HROW--Harrow Health, Inc. Nasdaq: HROW, an eye health pharmaceutical company focused on the development, production, sale, and distribution of innovative ophthalmic prescription medications that are accessible and affordable, today announced that it will release its financial results for the second quarter ended June 30, 2022, on Tuesday, August 9, 2022, after the market close. The Company will also post its second quarter Letter to Stockholders to the Investors 